Authors: Turban, S Fuentes, F Ferlic, L Brugada, R Gotto, AM Ballantyne, CM Marian, AJ

Citation: S. Turban et al., A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin, ATHEROSCLER, 154(3), 2001, pp. 633-640

Authors: Elghannam, H Tavackoli, S Ferlic, L Gotto, AM Ballantyne, CM Marian, AJ

Citation: H. Elghannam et al., A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy, J MOL MED-J, 78(10), 2000, pp. 562-568

Authors: Marian, AJ Safavi, F Ferlic, L Dunn, JK Gotto, AM Ballantyne, CM

Citation: Aj. Marian et al., Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin - The lipoprotein and coronary atherosclerosis study, J AM COL C, 35(1), 2000, pp. 89-95

Authors: Sing, K Ballantyne, CM Ferlic, L Brugada, R Cushman, I Dunn, JK Herd, JA Pownall, HJ Gotto, AM Marian, AJ

Citation: K. Sing et al., Lipoprotein lipase gene mutations, plasma lipid levels, progression regression of coronary atherosclerosis, response to therapy, and future clinical events - Lipoproteins and Coronary Atherosclerosis Study, ATHEROSCLER, 144(2), 1999, pp. 435-442